Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CD3E, GPRC5D (Talquetamab Biosimilar) anticorps

L’anticorps Humanized Monoclonal anti-CD3E, GPRC5D (Talquetamab Biosimilar) a été validé pour FACS. Il convient pour détecter CD3E, GPRC5D (Talquetamab Biosimilar) dans des échantillons de Humain.
N° du produit ABIN7093084

Aperçu rapide pour Recombinant CD3E, GPRC5D (Talquetamab Biosimilar) anticorps (ABIN7093084)

Antigène

CD3E, GPRC5D (Talquetamab Biosimilar)

Type d'anticorp

Recombinant Antibody

Reactivité

Humain

Hôte

  • 1
Humanized

Clonalité

  • 1
Monoclonal

Conjugué

  • 1
Cet anticorp CD3E, GPRC5D (Talquetamab Biosimilar) est non-conjugé

Application

  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Classe de qualité

Research Grade
  • Fonction

    Anti-GPRC5D (Talquetamab biosimilar) mAb

    Attributs du produit

    JNJ-64407564

    Purification

    Purified from cell culture supernatant by affinity chromatography

    Isotype

    IgG4
  • Indications d'application

    Flow Cyt 1:10

    Commentaires

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitute with deionized water

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

    Date de péremption

    12 months
  • Antigène

    CD3E, GPRC5D (Talquetamab Biosimilar)

    Autre désignation

    GPRC5D (Talquetamab Biosimilar)

    Classe de substances

    Biosimilar

    Sujet

    Synonyms: GPRC5D

    ID gène

    55507

    UniProt

    Q9NZD1
Vous êtes ici:
Chat with us!